2025-01-24 2026-01-31 2026-01-31 false 16206390 SIMPLYPHARMA CONSULTING LIMITED 2026-08-12 70229 false iso4217:GBP xbrli:pure 16206390 2025-01-23 16206390 2026-01-31 16206390 2025-01-24 2026-01-31 16206390 2025-01-22 16206390 2025-01-23 16206390 2025-01-23 2025-01-23 16206390 bus:SmallEntities 2025-01-24 2026-01-31 16206390 bus:AuditExempt-NoAccountantsReport 2025-01-24 2026-01-31 16206390 bus:FullAccounts 2025-01-24 2026-01-31 16206390 bus:PrivateLimitedCompanyLtd 2025-01-24 2026-01-31 16206390 core:WithinOneYear 2026-01-31 16206390 core:AfterOneYear 2026-01-31 16206390 core:WithinOneYear 2025-01-23 16206390 core:AfterOneYear 2025-01-23 16206390 core:ShareCapital 2026-01-31 16206390 core:SharePremium 2026-01-31 16206390 core:RevaluationReserve 2026-01-31 16206390 core:OtherReservesSubtotal 2026-01-31 16206390 core:RetainedEarningsAccumulatedLosses 2026-01-31 16206390 core:ShareCapital 2025-01-23 16206390 core:SharePremium 2025-01-23 16206390 core:RevaluationReserve 2025-01-23 16206390 core:OtherReservesSubtotal 2025-01-23 16206390 core:RetainedEarningsAccumulatedLosses 2025-01-23 16206390 core:LandBuildings 2026-01-31 16206390 core:PlantMachinery 2026-01-31 16206390 core:Vehicles 2026-01-31 16206390 core:FurnitureFittings 2026-01-31 16206390 core:OfficeEquipment 2026-01-31 16206390 core:NetGoodwill 2026-01-31 16206390 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 16206390 core:ListedExchangeTraded 2026-01-31 16206390 core:UnlistedNon-exchangeTraded 2026-01-31 16206390 core:LandBuildings 2025-01-23 16206390 core:PlantMachinery 2025-01-23 16206390 core:Vehicles 2025-01-23 16206390 core:FurnitureFittings 2025-01-23 16206390 core:OfficeEquipment 2025-01-23 16206390 core:NetGoodwill 2025-01-23 16206390 core:IntangibleAssetsOtherThanGoodwill 2025-01-23 16206390 core:ListedExchangeTraded 2025-01-23 16206390 core:UnlistedNon-exchangeTraded 2025-01-23 16206390 core:LandBuildings 2025-01-24 2026-01-31 16206390 core:PlantMachinery 2025-01-24 2026-01-31 16206390 core:Vehicles 2025-01-24 2026-01-31 16206390 core:FurnitureFittings 2025-01-24 2026-01-31 16206390 core:OfficeEquipment 2025-01-24 2026-01-31 16206390 core:NetGoodwill 2025-01-24 2026-01-31 16206390 core:IntangibleAssetsOtherThanGoodwill 2025-01-24 2026-01-31 16206390 core:ListedExchangeTraded 2025-01-24 2026-01-31 16206390 core:UnlistedNon-exchangeTraded 2025-01-24 2026-01-31 16206390 core:MoreThanFiveYears 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments 2026-01-31 16206390 core:Non-currentFinancialInstruments 2025-01-23 16206390 dpl:CostSales 2025-01-24 2026-01-31 16206390 dpl:DistributionCosts 2025-01-24 2026-01-31 16206390 core:LandBuildings 2025-01-24 2026-01-31 16206390 core:PlantMachinery 2025-01-24 2026-01-31 16206390 core:Vehicles 2025-01-24 2026-01-31 16206390 core:FurnitureFittings 2025-01-24 2026-01-31 16206390 core:OfficeEquipment 2025-01-24 2026-01-31 16206390 dpl:AdministrativeExpenses 2025-01-24 2026-01-31 16206390 core:NetGoodwill 2025-01-24 2026-01-31 16206390 core:IntangibleAssetsOtherThanGoodwill 2025-01-24 2026-01-31 16206390 dpl:GroupUndertakings 2025-01-24 2026-01-31 16206390 dpl:ParticipatingInterests 2025-01-24 2026-01-31 16206390 dpl:GroupUndertakings core:ListedExchangeTraded 2025-01-24 2026-01-31 16206390 core:ListedExchangeTraded 2025-01-24 2026-01-31 16206390 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-01-24 2026-01-31 16206390 core:UnlistedNon-exchangeTraded 2025-01-24 2026-01-31 16206390 dpl:CostSales 2025-01-23 2025-01-23 16206390 dpl:DistributionCosts 2025-01-23 2025-01-23 16206390 core:LandBuildings 2025-01-23 2025-01-23 16206390 core:PlantMachinery 2025-01-23 2025-01-23 16206390 core:Vehicles 2025-01-23 2025-01-23 16206390 core:FurnitureFittings 2025-01-23 2025-01-23 16206390 core:OfficeEquipment 2025-01-23 2025-01-23 16206390 dpl:AdministrativeExpenses 2025-01-23 2025-01-23 16206390 core:NetGoodwill 2025-01-23 2025-01-23 16206390 core:IntangibleAssetsOtherThanGoodwill 2025-01-23 2025-01-23 16206390 dpl:GroupUndertakings 2025-01-23 2025-01-23 16206390 dpl:ParticipatingInterests 2025-01-23 2025-01-23 16206390 dpl:GroupUndertakings core:ListedExchangeTraded 2025-01-23 2025-01-23 16206390 core:ListedExchangeTraded 2025-01-23 2025-01-23 16206390 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-01-23 2025-01-23 16206390 core:UnlistedNon-exchangeTraded 2025-01-23 2025-01-23 16206390 core:NetGoodwill 2026-01-31 16206390 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 16206390 core:LandBuildings 2026-01-31 16206390 core:PlantMachinery 2026-01-31 16206390 core:Vehicles 2026-01-31 16206390 core:FurnitureFittings 2026-01-31 16206390 core:OfficeEquipment 2026-01-31 16206390 core:AfterOneYear 2026-01-31 16206390 core:WithinOneYear 2026-01-31 16206390 core:ListedExchangeTraded 2026-01-31 16206390 core:UnlistedNon-exchangeTraded 2026-01-31 16206390 core:ShareCapital 2026-01-31 16206390 core:SharePremium 2026-01-31 16206390 core:RevaluationReserve 2026-01-31 16206390 core:OtherReservesSubtotal 2026-01-31 16206390 core:RetainedEarningsAccumulatedLosses 2026-01-31 16206390 core:NetGoodwill 2025-01-23 16206390 core:IntangibleAssetsOtherThanGoodwill 2025-01-23 16206390 core:LandBuildings 2025-01-23 16206390 core:PlantMachinery 2025-01-23 16206390 core:Vehicles 2025-01-23 16206390 core:FurnitureFittings 2025-01-23 16206390 core:OfficeEquipment 2025-01-23 16206390 core:AfterOneYear 2025-01-23 16206390 core:WithinOneYear 2025-01-23 16206390 core:ListedExchangeTraded 2025-01-23 16206390 core:UnlistedNon-exchangeTraded 2025-01-23 16206390 core:ShareCapital 2025-01-23 16206390 core:SharePremium 2025-01-23 16206390 core:RevaluationReserve 2025-01-23 16206390 core:OtherReservesSubtotal 2025-01-23 16206390 core:RetainedEarningsAccumulatedLosses 2025-01-23 16206390 core:NetGoodwill 2025-01-22 16206390 core:IntangibleAssetsOtherThanGoodwill 2025-01-22 16206390 core:LandBuildings 2025-01-22 16206390 core:PlantMachinery 2025-01-22 16206390 core:Vehicles 2025-01-22 16206390 core:FurnitureFittings 2025-01-22 16206390 core:OfficeEquipment 2025-01-22 16206390 core:AfterOneYear 2025-01-22 16206390 core:WithinOneYear 2025-01-22 16206390 core:ListedExchangeTraded 2025-01-22 16206390 core:UnlistedNon-exchangeTraded 2025-01-22 16206390 core:ShareCapital 2025-01-22 16206390 core:SharePremium 2025-01-22 16206390 core:RevaluationReserve 2025-01-22 16206390 core:OtherReservesSubtotal 2025-01-22 16206390 core:RetainedEarningsAccumulatedLosses 2025-01-22 16206390 core:AfterOneYear 2025-01-24 2026-01-31 16206390 core:WithinOneYear 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:CostValuation 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-24 2026-01-31 16206390 core:Non-currentFinancialInstruments core:CostValuation 2026-01-31 16206390 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-01-31 16206390 core:Non-currentFinancialInstruments core:CostValuation 2025-01-23 16206390 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-23 16206390 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-23 16206390 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-23 16206390 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-23 16206390 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-23 16206390 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-23 16206390 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-23 16206390 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-23 16206390 bus:Director1 2025-01-24 2026-01-31

SIMPLYPHARMA CONSULTING LIMITED

Registered Number
16206390
(England and Wales)

Unaudited Financial Statements for the Period ended
31 January 2026

SIMPLYPHARMA CONSULTING LIMITED
Company Information
for the period from 24 January 2025 to 31 January 2026

Director | COSLET, Alexandra

Registered Address | Suite A
| 82 James Carter Road
| Mildenhall
| IP28 7DE

Registered Number | 16206390 (England and Wales)

SIMPLYPHARMA CONSULTING LIMITED
Balance Sheet as at
31 January 2026

| Notes | 2026
--- | --- | ---
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 |  |  | 1,137
|  |  |  | 1,137
Current assets |  |  |  |
Debtors | 4 | 13,660 |  |
Cash at bank and on hand |  | 7,959 |  |
|  | 21,619 |  |
Creditors amounts falling due within one year | 5 | (16,097) |  |
Net current assets (liabilities) |  |  |  | 5,522
Total assets less current liabilities |  |  |  | 6,659
Provisions for liabilities | 6 |  |  | (216)
Net assets |  |  |  | 6,443
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 100
Profit and loss account |  |  |  | 6,343
Shareholders' funds |  |  |  | 6,443

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 12 August 2026, and are signed on its behalf by:
COSLET, Alexandra Director Registered Company No. 16206390

SIMPLYPHARMA CONSULTING LIMITED
Notes to the Financial Statements
for the period ended 31 January 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Employee benefits
--- | ---
| Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

| Current taxation
--- | ---
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax
--- | ---
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Tangible fixed assets and depreciation
--- | ---
| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

|  | Straight line (years)
| Office Equipment | 3

2. | Average number of employees
--- | ---

|  | 2026
| Average number of employees during the year | 1

3. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 1,318 |  | 1,318
| At 31 January 26 | 1,318 |  | 1,318
| Depreciation and impairment
| Charge for year | 181 |  | 181
| At 31 January 26 | 181 |  | 181
| Net book value
| At 31 January 26 | 1,137 |  | 1,137
| At 23 January 25 | - |  | -

4. | Debtors: amounts due within one year
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Trade debtors / trade receivables | 4,572
| Prepayments and accrued income | 9,088
| Total | 13,660

5. | Creditors: amounts due within one year
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Taxation and social security | 11,597
| Other creditors | 3,500
| Accrued liabilities and deferred income | 1,000
| Total | 16,097

6. | Provisions for liabilities
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Net deferred tax liability (asset) | 216
| Total | 216

7. | Directors advances, credits and guarantees
--- | ---
| Included within creditors: amounts falling due within one year were loans from the director of £3500. The loans were interest free, with no fixed date for repayment.